If approved, the vaccines would be the first publicly available against a respiratory virus that kills thousands every year.
A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Photo: Sarah Silbiger/Getty Images
A Food and Drug Administration advisory panel recommended Wednesday the second vaccine in two days against the respiratory syncytial virus,If approved by the FDA, the vaccines from GlaxoSmithKline and Pfizer would be the first publicly available against a respiratory virus that claims thousands of lives every year.RSV causes up to 10,000 deaths and as many as 160,000 hospitalizations for adults 65 years and older per year in the U.S.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
Les mer »
FDA panel narrowly backs Pfizer's RSV vaccine for older adultsFederal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against...
Les mer »
FDA panel narrowly backs Pfizer RSV vaccine for older adultsFederal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV.
Les mer »
FDA panel narrowly backs Pfizer RSV vaccine for older adultsFederal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV. rsv pfizer kprc2 click2houston
Les mer »
RSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsThe FDA, which typically follows the committee's recommendations, is expected to decide on approval of the vaccines in May, ahead of RSV's typical winter surge.
Les mer »
RSV vaccine: FDA advisers vote in favor of approval for vaccines for older adultsThe FDA, which typically follows the committee's recommendations, is expected to decide on approval of the vaccines in May, ahead of RSV's typical winter surge.
Les mer »